TY - JOUR
T1 - Purinergic P2Y2 receptors promote hepatocyte resistance to hypoxia
AU - Carini, Rita
AU - Alchera, Elisa
AU - De Cesaris, Maria Grazia
AU - Splendore, Roberta
AU - Piranda, Daniela
AU - Baldanzi, Gianluca
AU - Albano, Emanuele
N1 - Funding Information:
This work has been supported by grants from: University “Amedeo Avogadro” of East Piedmont, the Regional Government of Piedmont and the Italian Ministry for Instruction, University and Scientific Research (Research Program: Liver preconditioning: molecular mechanisms responsible for the modification of tolerance to ischemia/reperfusion and clinical application in liver resection and transplantation). G.B. is financially supported by the Centro Ricerche “E. Menni” Brescia, Italy.
PY - 2006/8
Y1 - 2006/8
N2 - Background/Aims: ATP stimulation of purinergic P2 receptors (P2YR and P2XR) regulates several hepatic functions. Here we report the involvement of ATP-mediated signals in enhancing hepatocyte tolerance to lethal stress. Methods: The protection given by purinergic agonists was investigated in rat hepatocytes exposed to hypoxia. Results: ATP released after hypotonic stress (200 mOsm/L) as well as P2YR agonists prevented hepatocyte killing by hypoxia with efficiency ranking UTP > ATPγS > ADPβS, whereas the P2XR agonist, methylene-adenosine-5′-triphosphate, was ineffective. Adenosine-5′-O-3-thiotriphosphate (ATPγS; 100 μmol/L) also prevented Na+-overload in hypoxic cells by inhibiting the Na+/H+ exchanger, without interfering with hypoxic acidosis. ATPγS activated Src and promoted a Src-dependent stimulation of both ERK1/2 and p38MAPK. Blocking p38MAPK with SB203580 reverted the protection given by ATPγS on both cell viability and Na+ accumulation, whereas ERK1/2 inhibition with PD98058 was ineffective. An increased phosphorylation of ERK1/2 was also evident in untreated hypoxic hepatocytes. PD98058 ameliorated Na+ accumulation and cell death caused by hypoxia. Hepatocyte pre-treatment with ATPγS reverted ERK1/2 activation in hypoxic cells. SB203580 blocked the effects of ATPγS on both ERK1/2 and Na+/H+ exchanger. Conclusions: The activation of p38MAPK by P2Y2R increases hepatocyte resistance to hypoxia by down-modulating ERK1/2-mediated signals that promote Na+ influx through the Na+/H+ exchanger.
AB - Background/Aims: ATP stimulation of purinergic P2 receptors (P2YR and P2XR) regulates several hepatic functions. Here we report the involvement of ATP-mediated signals in enhancing hepatocyte tolerance to lethal stress. Methods: The protection given by purinergic agonists was investigated in rat hepatocytes exposed to hypoxia. Results: ATP released after hypotonic stress (200 mOsm/L) as well as P2YR agonists prevented hepatocyte killing by hypoxia with efficiency ranking UTP > ATPγS > ADPβS, whereas the P2XR agonist, methylene-adenosine-5′-triphosphate, was ineffective. Adenosine-5′-O-3-thiotriphosphate (ATPγS; 100 μmol/L) also prevented Na+-overload in hypoxic cells by inhibiting the Na+/H+ exchanger, without interfering with hypoxic acidosis. ATPγS activated Src and promoted a Src-dependent stimulation of both ERK1/2 and p38MAPK. Blocking p38MAPK with SB203580 reverted the protection given by ATPγS on both cell viability and Na+ accumulation, whereas ERK1/2 inhibition with PD98058 was ineffective. An increased phosphorylation of ERK1/2 was also evident in untreated hypoxic hepatocytes. PD98058 ameliorated Na+ accumulation and cell death caused by hypoxia. Hepatocyte pre-treatment with ATPγS reverted ERK1/2 activation in hypoxic cells. SB203580 blocked the effects of ATPγS on both ERK1/2 and Na+/H+ exchanger. Conclusions: The activation of p38MAPK by P2Y2R increases hepatocyte resistance to hypoxia by down-modulating ERK1/2-mediated signals that promote Na+ influx through the Na+/H+ exchanger.
KW - Ischemia/reperfusion
KW - Liver injury
KW - Liver preconditioning
KW - Purinergic receptors
KW - Sodium accumulation
UR - https://www.scopus.com/pages/publications/33745685005
U2 - 10.1016/j.jhep.2006.02.017
DO - 10.1016/j.jhep.2006.02.017
M3 - Article
SN - 0168-8278
VL - 45
SP - 236
EP - 245
JO - Journal of Hepatology
JF - Journal of Hepatology
IS - 2
ER -